ACCoRd Trial to Test Ninlaro Treatment for ASCT-Relapsed Multiple Myeloma
News
A new Phase 3 clinical trial called ACCoRd is underway to investigate the benefits of adding Ninlaro (ixazomib) – a proteasome inhibitor – to the conditioning regimen prior to ... Read more